<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37686413</PMID><DateCompleted><Year>2023</Year><Month>09</Month><Day>11</Day></DateCompleted><DateRevised><Year>2023</Year><Month>10</Month><Day>12</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1422-0067</ISSN><JournalIssue CitedMedium="Internet"><Volume>24</Volume><Issue>17</Issue><PubDate><Year>2023</Year><Month>Sep</Month><Day>02</Day></PubDate></JournalIssue><Title>International journal of molecular sciences</Title><ISOAbbreviation>Int J Mol Sci</ISOAbbreviation></Journal><ArticleTitle>Elevation of Metrn&#x3b2; and Its Association with Disease Activity in Systemic Lupus Erythematosus.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">13607</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/ijms241713607</ELocationID><Abstract><AbstractText>Systemic lupus erythematosus (SLE) is an auto-immune disease, the pathogenesis of which remains to be fully addressed. Metrn&#x3b2; is a novel cytokine involved in the pathogenesis of inflammatory disease, but its regulatory roles in SLE are unclear. We aimed to comprehensively investigate the clinical value of Metrn&#x3b2; in SLE. A massive elevation of circulating Metrn&#x3b2; levels was observed in SLE, and patients with an active phase displayed higher Metrn&#x3b2; concentrations than those with inactive phases. Additionally, we found that Metrn&#x3b2; expression was positively correlated with clinical indicators of SLE. Longitudinal cytokine and chemokine profiles revealed a disturbed immune response in SLE, with high activity profiles displayed severe pathogenic inflammation, and a positive correlation of the serum Metrn&#x3b2; with CXCL9, IL10, IL18 and IL1RA was observed as well. Moreover, Metrn&#x3b2; expressions exhibited an inverse correlation with Treg and B10. Of note, a significant decrease of ILC2 was found in SLE, and there was a negative correlation of Metrn&#x3b2; with ILC2 as well. Further ROC analysis showed that the area under the curve (AUC) for Metrn&#x3b2; was 0.8250 (95% CI: 0.7379-0.9121), with a cutoff value of 1131 pg/mL to effectively distinguish SLE patients from healthy controls. Our study herein demonstrated for the first time that Metrn&#x3b2; values were increased and were immunologically correlated with SLE activity, which could be utilized as an alternative biomarker for the early identification and predicting of the immuno-response of SLE.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Chen</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Center of Clinical Laboratory Medicine, Zhongda Hospital, Southeast University, Nanjing 210009, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Epidemiology and Health Statistics, School of Public Health, Southeast University, Nanjing 210009, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cai</LastName><ForeName>Shijie</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Laboratory Medicine, Medical School of Southeast University, Nanjing 210009, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Ying</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Center of Clinical Laboratory Medicine, Zhongda Hospital, Southeast University, Nanjing 210009, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Xiaoyan</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Rheumatology, Zhongda Hospital, Southeast University, Nanjing 210009, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Yonghui</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Center of Clinical Laboratory Medicine, Zhongda Hospital, Southeast University, Nanjing 210009, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Qiao</LastName><ForeName>Huaiyu</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Center of Clinical Laboratory Medicine, Zhongda Hospital, Southeast University, Nanjing 210009, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wong</LastName><ForeName>Chun-Kwok</ForeName><Initials>CK</Initials><Identifier Source="ORCID">0000-0002-5637-8331</Identifier><AffiliationInfo><Affiliation>Department of Chemical Pathology, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Guoqiu</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Center of Clinical Laboratory Medicine, Zhongda Hospital, Southeast University, Nanjing 210009, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Laboratory Medicine, Medical School of Southeast University, Nanjing 210009, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jin</LastName><ForeName>Hui</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Epidemiology and Health Statistics, School of Public Health, Southeast University, Nanjing 210009, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key Laboratory of Environmental Medicine Engineering, Ministry of Education, School of Public Health, Southeast University, Nanjing 210009, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gao</LastName><ForeName>Xun</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Center of Clinical Laboratory Medicine, Zhongda Hospital, Southeast University, Nanjing 210009, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Laboratory Medicine, Medical School of Southeast University, Nanjing 210009, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>SYH-3201160-0054 (2023001)</GrantID><Agency>Special Funds for Research in Laboratory Medicine, Jiangsu Medical Association, Nanjing, China</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>09</Month><Day>02</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Int J Mol Sci</MedlineTA><NlmUniqueID>101092791</NlmUniqueID><ISSNLinking>1422-0067</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016207">Cytokines</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007113" MajorTopicYN="N">Immunity, Innate</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008214" MajorTopicYN="N">Lymphocytes</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008180" MajorTopicYN="Y">Lupus Erythematosus, Systemic</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001327" MajorTopicYN="Y">Autoimmune Diseases</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016207" MajorTopicYN="N">Cytokines</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ILC2</Keyword><Keyword MajorTopicYN="N">Metrn&#x3b2;</Keyword><Keyword MajorTopicYN="N">pathogenesis</Keyword><Keyword MajorTopicYN="N">systemic lupus erythematosus</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>7</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>8</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>8</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>9</Month><Day>11</Day><Hour>6</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>9</Month><Day>9</Day><Hour>11</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>9</Month><Day>9</Day><Hour>1</Hour><Minute>14</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37686413</ArticleId><ArticleId IdType="pmc">PMC10563073</ArticleId><ArticleId IdType="doi">10.3390/ijms241713607</ArticleId><ArticleId IdType="pii">ijms241713607</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Tsokos G.C. Systemic lupus erythematosus. N. Engl. J. Med. 2011;365:2110&#x2013;2121. doi: 10.1056/NEJMra1100359.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMra1100359</ArticleId><ArticleId IdType="pubmed">22129255</ArticleId></ArticleIdList></Reference><Reference><Citation>Terui H., Yamasaki K., Wada-Irimada M., Onodera-Amagai M., Hatchome N., Mizuashi M., Yamashita R., Kawabe T., Ishii N., Abe T., et al. Staphylococcus aureus skin colonization promotes SLE-like autoimmune inflammation via neutrophil activation and the IL-23/IL-17 axis. Sci. Immunol. 2022;7:eabm9811. doi: 10.1126/sciimmunol.abm9811.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciimmunol.abm9811</ArticleId><ArticleId IdType="pubmed">36306369</ArticleId></ArticleIdList></Reference><Reference><Citation>Woo J.M.P., Parks C.G., Jacobsen S., Costenbader K.H., Bernatsky S. The role of environmental exposures and gene-environment interactions in the etiology of systemic lupus erythematous. J. Intern. Med. 2022;291:755&#x2013;778. doi: 10.1111/joim.13448.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/joim.13448</ArticleId><ArticleId IdType="pubmed">35143075</ArticleId></ArticleIdList></Reference><Reference><Citation>Scheffschick A., Fuchs S., Malmstr&#xf6;m V., Gunnarsson I., Brauner H. Kidney infiltrating NK cells and NK-like T-cells in lupus nephritis: Presence, localization, and the effect of immunosuppressive treatment. Clin. Exp. Immunol. 2022;207:199&#x2013;204. doi: 10.1093/cei/uxab035.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cei/uxab035</ArticleId><ArticleId IdType="pmc">PMC8982963</ArticleId><ArticleId IdType="pubmed">35020891</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng M., Hu Z., Mei X., Ouyang L., Song Y., Zhou W., Kong Y., Wu R., Rao S., Long H., et al. Single-cell sequencing shows cellular heterogeneity of cutaneous lesions in lupus erythematosus. Nat. Commun. 2022;13:7489. doi: 10.1038/s41467-022-35209-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-35209-1</ArticleId><ArticleId IdType="pmc">PMC9722937</ArticleId><ArticleId IdType="pubmed">36470882</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma K., Du W., Xiao F., Han M., Huang E., Peng N., Tang Y., Deng C., Liu L., Chen Y., et al. IL-17 sustains the plasma cell response via p38-mediated Bcl-xL RNA stability in lupus pathogenesis. Cell. Mol. Immunol. 2021;18:1739&#x2013;1750. doi: 10.1038/s41423-020-00540-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41423-020-00540-4</ArticleId><ArticleId IdType="pmc">PMC8245411</ArticleId><ArticleId IdType="pubmed">32917979</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou Y., Liu L., Jin B., Wu Y., Xu L., Chang X., Hu L., Wang G., Huang Y., Song L., et al. Metrnl Alleviates Lipid Accumulation by Modulating Mitochondrial Homeostasis in Diabetic Nephropathy. Diabetes. 2023;72:611&#x2013;626. doi: 10.2337/db22-0680.</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/db22-0680</ArticleId><ArticleId IdType="pmc">PMC10130489</ArticleId><ArticleId IdType="pubmed">36812572</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee D.E., McKay L.K., Bareja A., Li Y., Khodabukus A., Bursac N., Taylor G.A., Baht G.S., White J.P. Meteorin-like is an injectable peptide that can enhance regeneration in aged muscle through immune-driven fibro/adipogenic progenitor signaling. Nat. Commun. 2022;13:7613. doi: 10.1038/s41467-022-35390-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-35390-3</ArticleId><ArticleId IdType="pmc">PMC9734561</ArticleId><ArticleId IdType="pubmed">36494364</ArticleId></ArticleIdList></Reference><Reference><Citation>Du Y.N., Teng J.M., Zhou T.H., Du B.Y., Cai W. Meteorin-like protein overexpression ameliorates fulminant hepatitis in mice by inhibiting chemokine-dependent immune cell infiltration. Acta Pharmacol. Sin. 2023;44:1404&#x2013;1415. doi: 10.1038/s41401-022-01049-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41401-022-01049-4</ArticleId><ArticleId IdType="pmc">PMC10310738</ArticleId><ArticleId IdType="pubmed">36721008</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu T.Y., Qing S.L., Zhao J.X., Song J., Miao Z.W., Li J.X., Yang F.Y., Zhao H.Y., Zheng S.L., Li Z.Y., et al. Metrnl deficiency retards skin wound healing in mice by inhibiting AKT/eNOS signaling and angiogenesis. Acta Pharmacol. Sin. 2023;44:1790&#x2013;1800. doi: 10.1038/s41401-023-01090-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41401-023-01090-x</ArticleId><ArticleId IdType="pmc">PMC10462726</ArticleId><ArticleId IdType="pubmed">37142683</ArticleId></ArticleIdList></Reference><Reference><Citation>Rao R.R., Long J.Z., White J.P., Svensson K.J., Lou J., Lokurkar I., Jedrychowski M.P., Ruas J.L., Wrann C.D., Lo J.C., et al. Meteorin-like is a hormone that regulates immune-adipose interactions to increase beige fat thermogenesis. Cell. 2014;157:1279&#x2013;1291. doi: 10.1016/j.cell.2014.03.065.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2014.03.065</ArticleId><ArticleId IdType="pmc">PMC4131287</ArticleId><ArticleId IdType="pubmed">24906147</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Z.Y., Song J., Zheng S.L., Fan M.B., Guan Y.F., Qu Y., Xu J., Wang P., Miao C.Y. Adipocyte Metrnl Antagonizes Insulin Resistance Through PPAR&#x3b3; Signaling. Diabetes. 2015;64:4011&#x2013;4022. doi: 10.2337/db15-0274.</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/db15-0274</ArticleId><ArticleId IdType="pubmed">26307585</ArticleId></ArticleIdList></Reference><Reference><Citation>Kerget B., Af&#x15f;in D.E., Kerget F., A&#x15f;k&#x131;n S., Akg&#xfc;n M. Is Metrnl an Adipokine &#x130;nvolved in the Anti-inflammatory Response to Acute Exacerbations of COPD? Lung. 2020;198:307&#x2013;314. doi: 10.1007/s00408-020-00327-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00408-020-00327-4</ArticleId><ArticleId IdType="pubmed">31960164</ArticleId></ArticleIdList></Reference><Reference><Citation>Ushach I., Arrevillaga-Boni G., Heller G.N., Pone E., Hernandez-Ruiz M., Catalan-Dibene J., Hevezi P., Zlotnik A. Meteorin-like/Meteorin-&#x3b2; Is a Novel Immunoregulatory Cytokine Associated with Inflammation. J. Immunol. 2018;201:3669&#x2013;3676. doi: 10.4049/jimmunol.1800435.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1800435</ArticleId><ArticleId IdType="pmc">PMC6394858</ArticleId><ArticleId IdType="pubmed">30464051</ArticleId></ArticleIdList></Reference><Reference><Citation>Scheinecker C., G&#xf6;schl L., Bonelli M. Treg cells in health and autoimmune diseases: New insights from single cell analysis. J. Autoimmun. 2020;110:102376. doi: 10.1016/j.jaut.2019.102376.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaut.2019.102376</ArticleId><ArticleId IdType="pubmed">31862128</ArticleId></ArticleIdList></Reference><Reference><Citation>Chun W., Tian J., Zhang Y. Transplantation of mesenchymal stem cells ameliorates systemic lupus erythematosus and upregulates B10 cells through TGF-&#x3b2;1. Stem Cell Res. Ther. 2021;12:512. doi: 10.1186/s13287-021-02586-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13287-021-02586-1</ArticleId><ArticleId IdType="pmc">PMC8466915</ArticleId><ArticleId IdType="pubmed">34563233</ArticleId></ArticleIdList></Reference><Reference><Citation>Sakkas L.I., Daoussis D., Mavropoulos A., Liossis S.N., Bogdanos D.P. Regulatory B cells: New players in inflammatory and autoimmune rheumatic diseases. Semin. Arthritis Rheum. 2019;48:1133&#x2013;1141. doi: 10.1016/j.semarthrit.2018.10.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.semarthrit.2018.10.007</ArticleId><ArticleId IdType="pubmed">30409417</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#xfc;ster M., Becker M., Gnirck A.C., Wunderlich M., Panzer U., Turner J.E. T cell-derived IFN-&#x3b3; downregulates protective group 2 innate lymphoid cells in murine lupus erythematosus. Eur. J. Immunol. 2018;48:1364&#x2013;1375. doi: 10.1002/eji.201747303.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/eji.201747303</ArticleId><ArticleId IdType="pubmed">29671873</ArticleId></ArticleIdList></Reference><Reference><Citation>Pan L., Lu M.P., Wang J.H., Xu M., Yang S.R. Immunological pathogenesis and treatment of systemic lupus erythematosus. World J. Pediatr. WJP. 2020;16:19&#x2013;30. doi: 10.1007/s12519-019-00229-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12519-019-00229-3</ArticleId><ArticleId IdType="pmc">PMC7040062</ArticleId><ArticleId IdType="pubmed">30796732</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou H., Hu B., Huang N., Mo X., Li W., Zhang B., Wei B., Gao M., Wang Y., Liu X., et al. Aberrant T cell subsets and cytokines expression profile in systemic lupus erythematosus. Clin. Rheumatol. 2018;37:2405&#x2013;2413. doi: 10.1007/s10067-018-4124-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10067-018-4124-0</ArticleId><ArticleId IdType="pubmed">29785672</ArticleId></ArticleIdList></Reference><Reference><Citation>Broca-Garcia B.E., Saavedra M.A., Mart&#xed;nez-Bencomo M.A., Montes-Cortes D.H., Jara L.J., Medina G., Vera-Lastra O., Cruz-Dominguez M.P. Utility of neutrophil-to-lymphocyte ratio plus C-reactive protein for infection in systemic lupus erythematosus. Lupus. 2019;28:217&#x2013;222. doi: 10.1177/0961203318821176.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0961203318821176</ArticleId><ArticleId IdType="pubmed">30661452</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu H., Han H., Li J., Li D., Jiang L. Alpha-hydroxybutyrate dehydrogenase as a biomarker for predicting systemic lupus erythematosus with liver injury. Int. Immunopharmacol. 2019;77:105922. doi: 10.1016/j.intimp.2019.105922.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.intimp.2019.105922</ArticleId><ArticleId IdType="pubmed">31669891</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo Y., Li X., Li R., Li Y., Wang Z., Liu H., Cao S., Li R., Zhao Y., Wang Q., et al. Utility of autoantibody against an UCH-L1 epitope as a serum diagnostic marker for neuropsychiatric systemic lupus erythematosus. Clin. Exp. Rheumatol. 2022;40:2078&#x2013;2087. doi: 10.55563/clinexprheumatol/0bjstd.</Citation><ArticleIdList><ArticleId IdType="doi">10.55563/clinexprheumatol/0bjstd</ArticleId><ArticleId IdType="pubmed">35084329</ArticleId></ArticleIdList></Reference><Reference><Citation>Falch C.M., Arlien-S&#xf8;borg M.C., Dal J., Sundaram A.Y.M., Michelsen A.E., Ueland T., Olsen L.G., Heck A., Bollerslev J., J&#xf8;rgensen J.O.L., et al. Gene expression profiling of subcutaneous adipose tissue reveals new biomarkers in acromegaly. Eur. J. Endocrinol. 2023;188:lvad031. doi: 10.1093/ejendo/lvad031.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ejendo/lvad031</ArticleId><ArticleId IdType="pubmed">36895180</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang S., Lei Y., Sun T., Gao Z., Li Z., Shen H. Elevated levels of Metrnl in rheumatoid arthritis: Association with disease activity. Cytokine. 2022;159:156026. doi: 10.1016/j.cyto.2022.156026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cyto.2022.156026</ArticleId><ArticleId IdType="pubmed">36084603</ArticleId></ArticleIdList></Reference><Reference><Citation>Bridgewood C., Russell T., Weedon H., Baboolal T., Watad A., Sharif K., Cuthbert R., Wittmann M., Wechalekar M., McGonagle D. The novel cytokine Metrnl/IL-41 is elevated in Psoriatic Arthritis synovium and inducible from both entheseal and synovial fibroblasts. Clin. Immunol. 2019;208:108253. doi: 10.1016/j.clim.2019.108253.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clim.2019.108253</ArticleId><ArticleId IdType="pubmed">31470086</ArticleId></ArticleIdList></Reference><Reference><Citation>Ji X., Wan J., Chen R., Wang H., Huang L., Wang S., Su Z., Xu H. Low frequency of IL-10-producing B cells and high density of ILC2s contribute to the pathological process in Graves&#x2019; disease, which may be related to elevated-TRAb levels. Autoimmunity. 2020;53:78&#x2013;85. doi: 10.1080/08916934.2019.1698553.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/08916934.2019.1698553</ArticleId><ArticleId IdType="pubmed">31809586</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou H., Zhao X., Zhang R., Miao M., Pei W., Li Z., Li Y., He J., Li Z., Sun X. Low-dose IL-2 mitigates glucocorticoid-induced Treg impairment and promotes improvement of SLE. Signal Transduct. Target. Ther. 2023;8:141. doi: 10.1038/s41392-023-01350-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41392-023-01350-6</ArticleId><ArticleId IdType="pmc">PMC10068597</ArticleId><ArticleId IdType="pubmed">37009820</ArticleId></ArticleIdList></Reference><Reference><Citation>Rauber S., Luber M., Weber S., Maul L., Soare A., Wohlfahrt T., Lin N.Y., Dietel K., Bozec A., Herrmann M., et al. Resolution of inflammation by interleukin-9-producing type 2 innate lymphoid cells. Nat. Med. 2017;23:938&#x2013;944. doi: 10.1038/nm.4373.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm.4373</ArticleId><ArticleId IdType="pmc">PMC5575995</ArticleId><ArticleId IdType="pubmed">28714991</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang X., Wang W., Xu J., Zhang M.S., Mei H., Shen Y., Zhang M.J., Ji X., Wang H. Significant association of CD4(+)CD25(+)Foxp3(+) regulatory T cells with clinical findings in patients with systemic lupus erythematosus. Ann. Transl. Med. 2019;7:93. doi: 10.21037/atm.2019.01.38.</Citation><ArticleIdList><ArticleId IdType="doi">10.21037/atm.2019.01.38</ArticleId><ArticleId IdType="pmc">PMC6462640</ArticleId><ArticleId IdType="pubmed">31019943</ArticleId></ArticleIdList></Reference><Reference><Citation>Geginat J., Vasco M., Gerosa M., Tas S.W., Pagani M., Grassi F., Flavell R.A., Meroni P., Abrignani S. IL-10 producing regulatory and helper T-cells in systemic lupus erythematosus. Semin. Immunol. 2019;44:101330. doi: 10.1016/j.smim.2019.101330.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.smim.2019.101330</ArticleId><ArticleId IdType="pubmed">31735515</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo C., Zhou M., Zhao S., Huang Y., Wang S., Fu R., Li M., Zhang T., Gaskin F., Yang N., et al. Innate lymphoid cell disturbance with increase in ILC1 in systemic lupus erythematosus. Clin. Immunol. 2019;202:49&#x2013;58. doi: 10.1016/j.clim.2019.03.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clim.2019.03.008</ArticleId><ArticleId IdType="pmc">PMC8191378</ArticleId><ArticleId IdType="pubmed">30926441</ArticleId></ArticleIdList></Reference><Reference><Citation>Amel-Kashipaz M.R., Huggins M.L., Lanyon P., Robins A., Todd I., Powell R.J. Quantitative and qualitative analysis of the balance between type 1 and type 2 cytokine-producing CD8(&#x2212;) and CD8(+) T cells in systemic lupus erythematosus. J. Autoimmun. 2001;17:155&#x2013;163. doi: 10.1006/jaut.2001.0525.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/jaut.2001.0525</ArticleId><ArticleId IdType="pubmed">11591124</ArticleId></ArticleIdList></Reference><Reference><Citation>Aringer M., Costenbader K., D&#xf6;rner T., Johnson S.R. Advances in SLE classification criteria. J. Autoimmun. 2022;132:102845. doi: 10.1016/j.jaut.2022.102845.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaut.2022.102845</ArticleId><ArticleId IdType="pubmed">35725680</ArticleId></ArticleIdList></Reference><Reference><Citation>Gladman D.D., Iba&#xf1;ez D., Urowitz M.B. Systemic lupus erythematosus disease activity index 2000. J. Rheumatol. 2002;29:288&#x2013;291.</Citation><ArticleIdList><ArticleId IdType="pubmed">11838846</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>